Table 1 Prevalence of associated symptoms in the study population
From: SARS COV-2 and other viral etiology as a possible clue for the olfactory dilemma
Symptom | Value |
|---|---|
General | |
 Fever, n (%) | 19 (31.7%) |
 Headache, n (%) | 38 (63.3%) |
 Malaise, n (%) | 47 (78.3%) |
Rhinological | |
 Nasal obstruction, n (%) | 16 (26.7%) |
 Nasal discharge, n (%) | 13 (21.7%) |
 Post-nasal discharge, n (%) | 5 (8.3%) |
 Sneezing, n (%) | 12 (20.0%) |
 Facial pain, n (%) | 13 (21.7%) |
Oropharyngeal | |
 Ageusia, n (%) | 52 (88.1%) |
 Dryness of mouth, n (%) | 9 (15.0%) |
 Sore throat, n (%) | 27 (45.0%) |
 Dysphagia, n (%) | 3 (5.0%) |
 Globus, n (%) | 5 (8.3%) |
Laryngeal | |
 Hoarseness, n (%) | 13 (21.7%) |
 Cough, n (%) | 19 (31.7%) |
Otological | |
 Otalgia, n (%) | 9 (15.0%) |
 Otorrhea, n (%) | 1 (1.7%) |
 Tinnitus, n (%) | 4 (6.7%) |
 Vertigo, n (%) | 8 (13.3%) |